BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

Tempus

Tempus logo

Website
https://www.tempus.com
Founded
2015
Patents
57
Publications
185

Technologies

AI Companies (Drug Discovery)

Tempus is a technology company that has built an operating system to battle cancer. It is on a mission to redefine how genomic data is used in a clinical setting. Their goal is for each patient to benefit from the treatment of others who came before by enabling physicians to deliver personalized cancer care for patients through interactive analytical and machine learning platform.

genomic profiling data licensing predictive test


Posts Mentioning This Company

Major VC Rounds For AI-driven Biotechs in 2020

July 8, 2020  
The ongoing COVID19 crisis forced biotech-oriented venture capitalists (VC) to somewhat slow down the pace of their usual deal-flow -- according to data by PitchBook biopharma venture deals in 2020 are down roughly 16% compared to last year.  However, there is still a lot going on in drug discovery and …
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

R&D Platform

To alleviate the amount of time clinicians must spend on their computers, Tempus has designed ONE as a portable device with the ability to relay all of the information contained in our reports along with vast amounts of relevant additional data regarding that patient, in real-time, seamlessly integrating into their existing workflow.

News

  • 2025-05-23
    Boehringer Ingelheim Taps Tempus’ AI and Patient Data to Deepen Cancer Research Pipeline
  • 2025-04-28
    Tempus Introduces Loop, an AI-Driven Platform for Target Discovery and Validation
  • 2024-05-22
    Tempus AI Files S-1 Registration to Go Public

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.